ACRV 8-K 2026-11-06

Acrivon Therapeutics, Inc. (ACRV) 8-K dated 2026-11-06 — accession 0001193125-26-450779.

Acrivon Therapeutics, Inc. (ACRV) is a biotechnology company listed on NASDAQ.

Acrivon Therapeutics, Inc. filed a 8-K on 2026-11-06. Accession 0001193125-26-450779.

This 8-K covers: Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Income-statement cache for ACRV is thin on this filing URL. We will not invent exhibit numbers.

Not investment advice. The ACRV SEC hub lists recent forms. The stock page is the research view.